Sort
48,018 grants matching “immunotherapy”
Co-Evolution Mechanisms of Pre-Cancer-Immune Interactions in Shaping Adaptive Cytotoxicity and Myeloid-Derived Suppression
$417,691Ken S Lau · Vanderbilt University Medical Center · U54 · FY2022 · CA
Role of Staphylococcus aureus alpha-hemolysin in disease
$417,650Juliane Bubeck Wardenburg · Washington University · R01 · FY2017 · AI
Targeting mechanisms of immune evasion in chemotherapy-induced senescent cells
$417,650James Jackson · Tulane University Of Louisiana · R01 · FY2025 · CA
Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy
$417,630Jin-Ming Yang · University Of Kentucky · R01 · FY2018 · CA
A Wireless Multi-function Microscope for Lifetime Imaging of the Brain Tumor Vasculome
$417,590Arvind P Pathak · Johns Hopkins University · R01 · FY2022 · CA
A platform for multi-modal single nucleus spatial genomics for molecular tumor analysis
$417,586Fei Chen · Broad Institute, Inc. · R33 · FY2024 · CA
CLINICAL THERAPY TRIALS
$417,566Katherine Kurshan Matthay · Children'S Hospital Of Los Angeles · P01 · FY2012 · CA
The Cellular and Transcriptional Control of CD8 T Cell Functional Adaptation to Chronic Viruses
$417,500Weiguo Cui · Versiti Wisconsin, Inc. · R01 · FY2016 · AI
Antibody therapy for pneumococcal disease
$417,500Liise-Anne Pirofski · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · AI
The Cellular and Transcriptional Control of CD8 T Cell Functional Adaptation to Chronic Viruses
$417,500Weiguo Cui · Versiti Wisconsin, Inc. · R01 · FY2017 · AI
Overcoming Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors
$417,500Aaron N Hata · Massachusetts General Hospital · R01 · FY2023 · CA
Protective Antibodies for Cryptococcal Infections
$417,500Albert Einstein Col Of Med Yeshiva Univ · R01 · FY2004 · AI
The Cellular and Transcriptional Control of CD8 T Cell Functional Adaptation to Chronic Viruses
$417,500Weiguo Cui · Versiti Wisconsin, Inc. · R01 · FY2019 · AI
The Cellular and Transcriptional Control of CD8 T Cell Functional Adaptation to Chronic Viruses
$417,500Weiguo Cui · Versiti Wisconsin, Inc. · R01 · FY2020 · AI
Elucidating the Function of PKC-theta in Alloreactivity and GVHD
$417,500Amer Aziz Beg · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · AI
Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo
$417,500Gregoire Stephane Lauvau · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · AI
Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo
$417,500Gregoire Stephane Lauvau · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · AI
Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo
$417,500Gregoire Stephane Lauvau · Albert Einstein College Of Medicine · R01 · FY2014 · AI
Role of TRIF-dependent TLR signaling in intestinal immunity
$417,500Masayuki Fukata · Cedars-Sinai Medical Center · R01 · FY2014 · AI
Role of TRIF-dependent TLR signaling in intestinal immunity
$417,500Masayuki Fukata · Cedars-Sinai Medical Center · R01 · FY2015 · AI
CHIMERIC SHIV MODEL FOR EVALUATING HIV IMMUNOTHERAPIES
$417,500Beth Israel Deaconess Medical Center · R01 · FY2001 · HL
Antibody therapy for pneumococcal disease
$417,500Liise-Anne Pirofski · Albert Einstein College Of Medicine · R01 · FY2020 · AI
Overcoming Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors
$417,500Aaron N Hata · Massachusetts General Hospital · R01 · FY2025 · CA
Antibody therapy for pneumococcal disease
$417,500Liise-Anne Pirofski · Albert Einstein College Of Medicine · R01 · FY2021 · AI
Gene circuits programming IL-17 production in innate lymphocytes
$417,500Joonsoo Kang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2014 · AI